Summary
The hypophosphatemic male mouse (Hyp/y), the proposed model for human vitamin D-resistant rickets (VDRR), is characterized by chronic hypophosphatemia, dwarfism, and rachitic and osteomalacic bone lesions. We have reported that treatment of Hyp/y mice with phosphate salts (Pi) heals rickets but does not correct the defective endosteal bone mineralization. In an attempt to cure osteomalacia, mutant male animals were treated with Pi combined with 25-hydroxyvitamin D3 (25OHD3, 1 µg/kg/day), 24,25-dihydroxyvitamin D3 [24,25(OH)2D3, 0.5 µg/kg/day], or 1,25-dihydroxyvitamin D3 [1,25(OH)2D3, 0.05–0.25 µg/kg/day] infused constantly for 3 weeks. The biochemical and skeletal effects of treatment were assessed by analytical methods and bone histomorphometry. The results show that only 1,25(OH)2D3 produced a dose-dependent elevation of serum calcium and phosphorus, and greatly improved bone mineralization at doses high enough to increase serum calcium and phosphorus concentrations within or above the normal range. Better improvement of bone mineralization was obtained when Pi was combined to 1,25(OH)2D3. In conjunction with the correction of hypocalcemia, Pi+1,25(OH)2D3 suppressed the stimulation of bone turnover induced by Pi supplementation. The results show that, as in VDRR children, 1,25(OH)2D3 produces beneficial effects on bone lesions in Hyp/y mice, mainly through enhancement of mineral availability. However, the persistence of osteomalacia despite correction of serum mineral concentrations suggests that there is a specific bone cell resistance to mineral and/or hormonal influences in Hyp/y mice.
Similar content being viewed by others
References
Eicher, E. M., Southard, J. L., Scriver, C. R., Glorieux, F. H.: Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets, Proc. Natl. Acad. Sci. U.S.A.73:4667–4671, 1976
Cowgill, L. D., Goldfarb, S., Lau, K., Slatopolsky, E., Agus, Z. S.: Evidence for an intrinsic renal tubular defect in mice with genetic hypophosphatemic rickets, J. Clin. Invest.63:1203–1210, 1979
Meyer, R. A., Jr., Jowsey, J., Meyer, M. H.: Osteomalacia and altered magnesium metabolism in the X-linked hypophosphatemic mouse, Calcif. Tissue Int.27:19–26, 1979
Tenenhouse, H. S., Scriver, C. R., McInness, R. R., Glorieux, F. H.: Renal handling of phosphate in vivo and in vitro by X-linked hypophosphatemic male mouse: Evidence for a defect in the brush border membrane, Kidney Int.14:236–244, 1978
Meyer, R. A., Jr., Gray, R. W., Kiebzak, G. M., Mish, P. M.: Altered vitamin D and trace mineral metabolism in the X-linked hypophosphatemic (Hyp) mouse. In S. G. Massry (ed.): Fourth International Workshop on Phosphate and Other Minerals. Plenum Press, New York, in press
O'Doherty, P. J. A., DeLuca, H. F., Eicher, E. M.: Lack of effect of vitamin D and its metabolites on intestinal phosphate transport in familial hypophosphatemia of mice, Endocrinology101:1325–1330, 1977
Beamer, W. G., Wilson, M. C., DeLuca, H. F.: Successful treatment of genetically hypophosphatemic mice by 1α-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3, Endocrinology106:1949–1955, 1980
Marie, P. J., Travers, R., Glorieux, F. H.: Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse, J. Clin. Invest.67:911–914, 1981
Haddad, J. G., Chyu, K. J.: Competitive protein-binding radioassay for 25-hydroxycholecalciferol, J. Clin. Endocrinol Metab.33:922–925, 1971
Eisman, J. A., Hamstra, A. J., Kream, B. E., DeLuca, H. F.: A sensitive, precise and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma, Arch. Biochem. Biophys.176:235–243, 1976
Haddad, J. G., Min, C., Mendelsohn, M., Slatopolsky, E., Hahn, T. J.: Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects, Arch. Biochem. Biophys.182:390–395, 1977
Delvin, E. E., Glorieux, F. H.: Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets, Calcif. Tissue Res.33:173–175, 1981
Bordier, P. J., Tun-Chot, S.: Quantitative histology of metabolic bone disease, J. Clin. Endocrinol. Metab.1:197–215, 1972
Villanueva, A. R.: Methods of preparing and interpreting mineralized sections of bone. In Z. F. G. Jaworski (ed.): Proceedings of the First Workshop on Bone Morphometry, pp. 341–353. University of Ottawa Press, Ottawa, 1973
Dunnett, C. W.: A multiple comparison procedure for comparing several treatments with a control, J. Am. Stat. Assoc.50:1096–1121, 1955
Harris, W. H., Heaney, R. P., Davis, L. A., Weinberg, E. H., Coutts, R. D., Schiller, A. L.: Stimulation of bone formation in vivo by phosphate supplementation, Calcif. Tissue Res.22:85–98, 1976
Glorieux, F. H., Marie, P. J., Pettifor, J. M., Delvin, E. E.: Bone response to phosphate salts, ergocalciferol and calcitriol in hypophosphatemic vitamin-D resistant rickets, N. Engl. J. Med.303:1023–1031, 1980
Malluche, H. H., Henry, H., Meyer-Sabellek, W., Sherman, D., Massry, S. G., Norman, A. W.: Effects and interactions of 24R, 25(OH)2D3 and 1,25(OH)2D3 on bone, Am. J. Physiol.238(Endocrinol. Metab. 1): E494–498, 1980
Bordier P., Rasmussen, H., Marie, P., Miravet, L., Gueris, J., Ryckwaert, A.: Vitamin D metabolites and bone mineralization in man, J. Clin. Endocrinol. Metab.46:284–293, 1978
Glorieux, F. H., Bordier, P. J., Marie, P. J., Delvin, E. E., Travers, R.: Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets. In S. G. Massry, E. Ritz, A. Rapado (eds): Homeostasis of phosphate and others minerals. Adv. Exp. Med. Biol.103:227–232, 1978
Weisbrode, S. E., Capen, C. C., Norman, A. W.: Influence of diet on the response of bone cells to 1,25-(OH)2D3 in thyroparathyroidectomized rats. In A. W. Norman, K. Schaefer, D. V. Herrath, H.-G. Grigoleit, J. W. Coburn, H. F. DeLuca, E. B. Mawer, T. Suda (eds.): Vitamin D, Basic Research and Its Clinical Application, pp. 415–418. Walter de Gruyter, Berlin, New York, 1979
Meunier, P. J., Edouard, C., Arlot, M., Lejeune, E., Alexandre, C., Leroy, G.: Effects of 1,25-dihydroxyvitamin D on bone mineralization. In I. MacIntyre, M. Szelke (eds.): Molecular Endocrinology, pp. 283–292. Elsevier-North Holland Biomedical Press, Amsterdam, 1979
Villanueva, A. R., Ilnicki, L., Frost, H. M., Arnstein, R.: Measurement of the bone formation rate in a case of familial hypophosphatemic vitamin D-resistant rickets, J. Lab. Clin. Med.67:973–982, 1966
Marie, P. J., Glorieux, F. H.: Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets, Metab. Bone Dis. Rel. Res., in press
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marie, P.J., Travers, R. & Glorieux, F.H. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int 34, 158–164 (1982). https://doi.org/10.1007/BF02411227
Issue Date:
DOI: https://doi.org/10.1007/BF02411227